Photodynamic Therapy of Actinic Keratoses With Alacare®
Sponsored by photonamic GmbH & Co. KG
About this trial
Last updated 9 years ago
Study ID
NIS 01
Status
Completed
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 9 years ago
What is this trial about?
This study aims to collect data on the frequency of SCCs in the Alacare®-treated area
during an interval of two years after Alacare®-PDT.
What are the participation requirements?
Inclusion Criteria
- Written informed consent
- Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC